Verastem (VSTM) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Verastem (VSTM) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -41.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.70% |
| Dec 31, 2025 | -262.55% |
| Sep 30, 2025 | 73.39% |
| Jun 30, 2025 | 75.25% |
| Mar 31, 2025 | -499.49% |
| Dec 31, 2024 | 69.72% |
| Sep 30, 2024 | -70.90% |
| Jun 30, 2024 | 11.28% |
| Mar 31, 2024 | 75.43% |
| Dec 31, 2023 | -291.31% |
| Sep 30, 2023 | 17.19% |
| Jun 30, 2023 | 45.87% |
| Mar 31, 2023 | 61.93% |
| Dec 31, 2022 | 98.59% |
| Sep 30, 2022 | -1,456.69% |
| Jun 30, 2022 | -3,861.11% |
| Mar 31, 2022 | -2,568.93% |
| Dec 31, 2021 | -13,243.62% |
| Sep 30, 2021 | -118.50% |
| Jun 30, 2021 | 92.58% |